Veru Presents New Results at ObesityWeek 2026: GLP-1 Weight Loss in Older Adults Associated with Physical Function Decline; Adding Enobosarm Preserved Significant Lean Mass and Physical Function
— In a post hoc analysis of patients ≥65 years from the positive Phase 2b QUALITY study, those on semaglutide + placebo lost significant lean mass and had reduced stair climb power

Follow